Mike Goonewardene was recently appointed as the chief commercial officer of Sterifre Medical, Inc., where he will lead business development, sales, marketing, clinical support and customer service for the company. Sterifre is commercializing a suite of products based on innovative, patented, disinfection technology that addresses the growing demand for rapid, point-of-care infection control in healthcare facilities.
Goonewardene comes to Sterifre following executive roles with leading healthcare companies in the compliance, safety, and infection-control market. He was one of the original employees at Stericycle Inc. with responsibility for developing and implementing the startup business plan that led to its growth to $3.5 billion. He went on to serve as corporate vice president for BioSystems, a Stericycle company, building the team that implemented adoption of a unique sharps safety product/service at more than 3,000 U.S. hospitals. After the IPO, Goonewardene was the company’s vice president and general manager of the international business, successfully leading global product development and international expansion. He completed 24 international acquisitions and created business entities in multiple countries. Goonewardene previously served as chief operating officer at ClearMedical, a medical device company focused on the high-level disinfection of single-use medical devices to support economical, FDA-approved reprocessing. The business was successfully sold to Johnson & Johnson.
Additionally, Goonewardene serves on the board of directors of Trinity Guardion, a novel infection control company developing a patented barrier technology that targets the reduction of C. diff. and other healthcare-acquired infections associated with patient beds. He recently completed 15 years of board service for the Western States Healthcare Materials Management Association.
Goonewardene received his MBA from President and Key Executive (PKE) program at the Graziadio Business School in 2001.